Delivery Order SPE2DB22D2214-SPE2DB23FS4VP
Award Date 5/18/23
Potential Completion Date 5/19/23
Potential Value $1.7K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The federal contract award is for the delivery of Olopatadine HCL 0.1% eye drops, 5 ml, to the Defense Logistics Agency (DLA). The $1,891.61 firm fixed price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 16, 2024 with a completion date of December 17, 2024. This appears to be a one-time delivery order rather than a larger indefinite delivery vehicle. The contract does not have a set-aside designation....
- This federal contract award is for the delivery of Olopatadine HCL 0.1% eye drops in 5ml packages. The contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on a Firm Fixed Price basis. The contract has a ceiling value of $1,026.12 and a completion date of January 30, 2024. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does...
- This award is a delivery order contract valued at $2,129.24 for the supply of Olopatadine HCl 0.1% eye drops (5ml) to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Olopatadine HCL 0.1% eye drops in 5 mL containers. The fixed-price, firm-fixed delivery order contract has an ultimate completion date of March 2, 2023 and a ceiling value of $2,777.51. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. for the delivery of Olopatadine Hydrochloride 0.1% Eye Drops in 5 mL containers. The award, with a ceiling value of $2,085.00, is a Firm Fixed Price Delivery Order contract with a completion date of August 2, 2024. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp.'s Corporate Office Division is the prime contractor for this award, which is part...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of Olopatadine Hydrochloride 0.1% eye drops. The $1,297.14 delivery order is a firm-fixed price contract with an ultimate completion date of April 24, 2024. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 with the DLA Troop Support Medical, which serves as the primary...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,274.35 firm fixed price delivery order covers the procurement of OLOPATADINE HCL 0.1% EYE DROPS 5ML, a specialty pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract is for the delivery of Olopatadine HCL 0.1% eye drops, a prescription medication, with a ceiling value of $1,305.12 and a performance period through June 2025. The contract is a delivery order, with a firm fixed price pricing type, and is not designated as a set-aside. Amerisourcebergen holds a...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $1,308.39, is for the delivery of OLOPATADINE HCL 0.1% eye drops in 5ml quantities. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for...
- The federal contract award to Amerisourcebergen Drug Corp., a major pharmaceutical distributor, is for the delivery of olopatadine hydrochloride 0.1% eye drops in 5ml vials. The $4,862.96 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) on November 27, 2024, with a completion date of November 29, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) the company holds with the DLA Troop Support Medical, which serves as a primary...